[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358713-105":59,"doc-detail-358713-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rational-engineering-of-combinatorial-bacterial-therapies-for-cancer","Rational engineering of combinatorial bacterial therapies for cancer","","Engineered bacteria are emerging as a transformative class of cancer therapeutics. Synthetic biology has expanded genetic circuit capabilities, enabling programmable control of attenuation, payload release, and immunomodulation. These advances shift bacteria from simple colonizers to versatile chassis for complex therapeutic functions. The review evaluates circuit-based strategies to increase tumor specificity, regulate therapeutic delivery, engage host immunity, and implement spatiotemporal control and consortium behavior, while addressing barriers to clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rational-engineering-of-combinatorial-bacterial-therapies-for-cancer/358713/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rational-engineering-of-combinatorial-bacterial-therapies-for-cancer/358713.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-09-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":81},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role do synthetic biology tools play in bacterial cancer therapies?","Question",{"text":112,"@type":113},"They expand genetic circuit design, enabling programmable control of attenuation, payload release, and immunomodulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why are solid tumors difficult targets for conventional cancer treatments?",{"text":117,"@type":113},"Their irregular vasculature, metabolic heterogeneity, and necrotic regions limit delivery and efficacy, while systemic or repeated exposure can cause toxicity in healthy tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What advantages do engineered bacteria offer for tumor specificity and immune engagement?",{"text":121,"@type":113},"Bacterial properties can remodel tumor architecture, selectively colonize hypoxic/necrotic regions, and activate localized antitumor immune responses through innate immunogenicity; engineered circuits further enable dynamic tumor microenvironment-responsive behavior.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},358713,1790214172,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":81,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Steppe et al. Genome Biology (2026) 27:53 [https://doi.org/10.1186/s13059-026-03951-0](https://doi.org/10.1186/s13059-026-03951-0)  \nGenome Biology  \nREVIEW Open Access  \nRational engineering of combinatorial bacterial therapies for cancer  \nPaige Steppe1†, Katherine O’Connor1† and Jeff Hasty1,2,3*  \n\n| †Paige Steppe and Katherine O’Connor contributed equally to this work. |\n| --- |\n| *Correspondence:\u003Cbr>[jhasty@ucsd.edu](jhasty@ucsd.edu) |\n\n1 Department of Bioengineering, University of California San Diego, 9500 Gilman Drive, La Jolla 92093, CA, United States  \n2 Molecular Biology Section, Division of Biological Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla 92093, CA, United States  \n3 Synthetic Biology Institute, University of California San Diego, 9500 Gilman Drive, La Jolla 92093, CA, United States  \nAbstract  \nEngineered bacteria are emerging as a transformative class of cancer therapeutics. Recent advances in synthetic biology have expanded the genetic circuit toolbox, enabling the programmable control of attenuation, payload release, and immunomodulation. These developments have transformed bacteria from simple, colonizing agents into a versatile chassis for complex therapeutic functions. In this review, we examine recent circuit-based strategies for enhancing tumor specificity, regulating therapeutic delivery and engaging the host immune system, with emphasis on programming spatiotemporal control and consortia behavior. We consider current barriers to clinical translational and discuss how rational engineering can guide the next generation of microbial therapeutics.  \nKeywords: Tumor microenvironment, Synthetic Biology, Cell therapy, Bacteria, CAR-T, Immunotherapy  \nIntroduction  \nThe convergence of synthetic biology and oncology has transformed bacteria from passive tumor colonizers into programmable living therapeutics. Although traditional cancer treatments like chemotherapy, radiotherapy, and immunotherapy, have dramatically improved patient outcomes, no single modality can fully address the biological and spatial complexity of solid tumors [1–3]. Irregular vasculature, metabolic heterogeneity, and necrotic regions limit the delivery and efficacy of conventional therapies, while systemic or repeated drug exposure can lead to dose-limiting toxicity in healthy tissues [4–6]. Bacterial species offer an alternative therapeutic option uniquely suited to these challenges: they remodel tumor architecture, activate localized antitumor immune responses through innate immunogenicity, and selectively colonize hypoxic and necrotic tumor regions [7, 8]. These natural properties provide a foundation for engineering bacteria as disease-specific therapeutic platforms capable of precision delivery within the tumor microenvironment (TME).  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nSteppe et al. Genome Biology (20","cbCaim5JvqEoxcxT","https://ap.wps.com/l/cbCaim5JvqEoxcxT","pdf",1513775,14,"English","# Abstract\n# Introduction\n## Challenges in solid tumor treatment\n## Bacteria as programmable therapeutic platforms\n# Engineering strategies highlighted in the review","[{\"question\":\"What role do synthetic biology tools play in bacterial cancer therapies?\",\"answer\":\"They expand genetic circuit design, enabling programmable control of attenuation, payload release, and immunomodulation.\"},{\"question\":\"Why are solid tumors difficult targets for conventional cancer treatments?\",\"answer\":\"Their irregular vasculature, metabolic heterogeneity, and necrotic regions limit delivery and efficacy, while systemic or repeated exposure can cause toxicity in healthy tissues.\"},{\"question\":\"What advantages do engineered bacteria offer for tumor specificity and immune engagement?\",\"answer\":\"Bacterial properties can remodel tumor architecture, selectively colonize hypoxic/necrotic regions, and activate localized antitumor immune responses through innate immunogenicity; engineered circuits further enable dynamic tumor microenvironment-responsive behavior.\"}]","Rational engineering of combinatorial bacterial therapies for cancer | PDF",1790135047,35]